October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an exclusive partnership with Cardiac Imaging, Inc., of Oakbrook Terrace, Illinois, to provide a daily-leased rubidium solution to healthcare facilities interested in performing cardiac PET.

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando, Florida, putting the spotlight on the value of ACC Accreditation and NCDR services to enhance health care quality. Cardiovascular clinicians and stakeholders across the U.S.

October 5, 2023 — Mayo Clinic researchers have developed a calculation that can help identify moderate 

October 4, 2023 — MedAxiom, a premier source for cardiovascular organizational performance solutions, has released its 2023 Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut.

October 4, 2023 — Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and 

October 5, 2023 — A newly-issued "Scientific Statement on Durable Mechanical Circulatory Support" in the October issue of the Journal of the American College of Cardiology, JACC, covers the use of durable mechanical circulatory support, referring to it as an important but often underutilized treatm

October 4, 2023 — The American College of Cardiology (ACC) recently announced that it has started a strategic innovation collaboration with Serv Medical, a Singapore-based healthcare big data and artificial intelligence (AI) company. The goal, according to a written statement, is revolutionizing cardiovascular care through digital therapeutics and fostering medical excellence in developing markets.

October 3, 2023 — EnCompass Technologies, Inc., a privately held medical device company focused on protecting patients from brain injury during cardiovascular procedures, announced the US Food and Drug Administration (FDA) officially granted conditional Investigational Device Exemption (IDE) approval for its F2 cerebral embolic protection system on Friday, September 22, 2023. 

October 3, 2023 -- Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation insertable monitor for long-term monitoring of arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now